PMID- 37169170 OWN - NLM STAT- MEDLINE DCOM- 20230703 LR - 20230703 IS - 1873-1597 (Electronic) IS - 1572-1000 (Linking) VI - 42 DP - 2023 Jun TI - Short-term effect of macular edema on the peripapillary retinal nerve fiber layer in patients with wet age-related macular degeneration and diabetic macular edema: A comparative study. PG - 103602 LID - S1572-1000(23)00329-0 [pii] LID - 10.1016/j.pdpdt.2023.103602 [doi] AB - BACKGROUND: The combined presence of glaucoma and age-related macular degeneration (ARMD), or glaucoma and diabetes mellitus (DM), occur fairly frequently, especially in elderly patients. This study was intended to compare the effect of resolving macular edema due to DM and wet ARMD on peripapillary retinal nerve fiber layer (RNFL) thickness. METHODS: This cross-sectional study included 76 patients with macular edema secondary to DM (n = 40, 52.6%) or wet ARMD (n = 36, 47.4%). The control group was comprised of 34 age and sex-matched healthy subjects. All study participants underwent evaluation of central macular thickness (CMT) and the peripapillary RNFL using spectral domain-optical coherence tomography (SD-OCT). Data from eyes that received an anti-VEGF injection were obtained one month after the procedure and were compared with pre-injection data. RESULTS: The average initial thickness of the global peripapillary RNFL was 98.9 +/- 16.7 (61-163) microm in the macular edema group and 92.0 +/- 16.0 (84-115) microm in the control group (p = 0.045). The post-injection global peripapillary RNFL thickness was 97.3 +/- 19.0 (61-163) microm in the macular edema group and 92.2 +/- 18.0 (81-126) microm in the control group (p = 0.187). In the DM group, the changes in global RNFL thickness, as well as central and temporal quadrant thicknesses, were found to correlate significantly with the change in CMT (r = 0.356, p = 0.024; r = 0.545, p < 0.001, respectively). CONCLUSIONS: Macular edema in wet ARMD appeared not to affect RNFL thickness. Differences in the etiology of macular edema can have varied effects on peripapillary RNFL. It is recommended that peripapillary RNFL thickness be evaluated cautiously in DM patients receiving intravitreal anti-VEGF therapy. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Dikmetas, Ozlem AU - Dikmetas O AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. Electronic address: ozlemdikmetas@gmail.com. FAU - Gungor, Gulce AU - Gungor G AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Kapucu, Yasemin AU - Kapucu Y AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Kocabeyoglu, Sibel AU - Kocabeyoglu S AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Kadayifcilar, Sibel AU - Kadayifcilar S AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Eldem, Bora AU - Eldem B AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Karahan, Sevilay AU - Karahan S AD - Department of Biostatistics, Hacettepe University School of Medicine, Ankara, Turkey. FAU - Cankaya, Ali Bulent AU - Cankaya AB AD - Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. LA - eng PT - Journal Article DEP - 20230509 PL - Netherlands TA - Photodiagnosis Photodyn Ther JT - Photodiagnosis and photodynamic therapy JID - 101226123 RN - 0 (Photosensitizing Agents) SB - IM MH - Humans MH - Aged MH - *Macular Edema/drug therapy MH - *Diabetic Retinopathy/complications/drug therapy MH - Cross-Sectional Studies MH - Retinal Ganglion Cells MH - *Photochemotherapy/methods MH - Photosensitizing Agents MH - *Glaucoma/complications MH - Tomography, Optical Coherence/methods MH - Nerve Fibers MH - *Diabetes Mellitus OTO - NOTNLM OT - Age-related macular degeneration OT - Diabetic macular edema OT - Macular edema OT - OCT OT - Peripapillary retinal nerve fiber layer EDAT- 2023/05/12 01:07 MHDA- 2023/07/03 06:41 CRDT- 2023/05/11 19:34 PHST- 2023/01/15 00:00 [received] PHST- 2023/04/19 00:00 [revised] PHST- 2023/05/08 00:00 [accepted] PHST- 2023/07/03 06:41 [medline] PHST- 2023/05/12 01:07 [pubmed] PHST- 2023/05/11 19:34 [entrez] AID - S1572-1000(23)00329-0 [pii] AID - 10.1016/j.pdpdt.2023.103602 [doi] PST - ppublish SO - Photodiagnosis Photodyn Ther. 2023 Jun;42:103602. doi: 10.1016/j.pdpdt.2023.103602. Epub 2023 May 9.